Cadinha & CO LLC Bristol Myers Squibb CO Transaction History

Cadinha & CO LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 25, 2023	SELL	$68.48 - $81.09 $60,467 - $71,602	-883 Reduced 23.76%	2,834 $0
Q3 2022 Oct 21, 2022	SELL	$0.13 - $76.84 $25,085 - $14.8 Million	-192,963 Reduced 98.11%	3,717 $264,000
Q2 2022 Aug 05, 2022	BUY	$72.62 - $79.98 $14.3 Million - $15.7 Million	196,680 New	196,680 $15.1 Million
Q4 2018 Jan 29, 2019	SELL	$48.76 - $63.23 $943,652 - $1.22 Million	-19,353 Closed	0 $0
Q3 2018 Nov 07, 2018	SELL	$55.19 - $62.25 $10.7 Million - $12.1 Million	-193,623 Reduced 90.91%	19,353 $1.2 Million
Q2 2018 Aug 07, 2018	SELL	$50.53 - $62.98 $47,851 - $59,642	-947 Reduced 0.44%	212,976 $11.8 Million
Q1 2018 May 10, 2018	BUY	$59.92 - $68.98 $18,814 - $21,659	314 Added 0.15%	213,923 $13.5 Million
Q4 2017 Jan 29, 2018	BUY	$59.94 - $65.35 $2.18 Million - $2.37 Million	36,309 Added 20.48%	213,609 $13.1 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $9.79 Million - $11.3 Million	177,300	177,300 $11.3 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Cadinha & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Cadinha & CO LLC with notifications on news.